Nikko Asset Management Americas Inc. 13D and 13G filings for Syros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:06 am Sale | 2021-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Nikko Asset Management Americas Inc. | 0 0.000% | -438,199 (Position Closed) | Filing |
| 2021-02-11 5:27 pm Sale | 2020-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Nikko Asset Management Americas Inc. | 438,199 9.570% | -59,267 (-11.91%) | Filing |